Answers are grounded in this paper and cite their sources.
Objectives: The goal of this work was to formulate a stable naringenin-loaded cubosomal in situ gel to improve naringenin absorption into the brain by direct nose-to-brain transfer. Materials and Methods: This investigation aimed to prepare, optimize and evaluate a cubosomal in situ gel containing naringenin, aimed at facilitating the delivery of the drug to the brain via nasal administration. Cubosomes were fabricated using a top-down methodology and optimization was conducted using 32 factorial designs. Cubosomes were analyzed for particle size, encapsulation efficiency, zeta potential and cumulative percent drug release. Poloxamer-407 was used as a thermoreversible and mucoadhesive polymer for preparing naringenin-loaded cubosomal in situ gel. Results: The optimized cubosome formulation (F3) containing 3% Glyceryl Monooleate (GMO) and 1.5% poloxamer, exhibited a particle size of 123.2 nm, an encapsulation efficiency of 71.12% and a zeta potential of -38.61. The Transmission Electron Microscopy (TEM) image represented the smooth cubic structure of naringenin-loaded cubosomes. The thermoreversible in situ gel demonstrated appropriate gelation temperatures, viscosities, pH levels and in vitro drug diffusion characteristics. The in vitro drug diffusion study revealed a higher percentage cumulative drug release, reaching 82.21%. Conclusion: The results obtained demonstrated enhanced capability of the developed naringenin-loaded cubosomes to facilitate drug permeation through the nasal cavity.
No takes yet. Share an insight, caveat, or question.
Raut et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: